Exponent (EXPO) Form 144: Option Exercise Sale of 4,896 Shares

Rhea-AI Filing Summary

Notice of proposed sale under Rule 144 for Exponent Inc (EXPO). The filer proposes to sell 4,896 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $355,694.40. The securities are listed on NASDAQ and approximately dated for sale on 08/14/2025. The shares were acquired on 08/14/2025 by exercise of stock options from the issuer and payment was made in cash on the same date. The form states there were no securities sold in the past three months by the reporting person and includes the standard representation that the signer does not possess undisclosed material adverse information.

Positive

• Complete transaction details provided: class, number of shares, aggregate value, broker, exchange, and sale date are all disclosed
• Acquisition method disclosed: shares were acquired by exercise of stock options and paid in cash on the acquisition date
• No prior sales in past 3 months: the filing states Nothing to Report for securities sold during the past three months

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice for exercised options, procedural and compliance details are present.

The filing documents a routine proposed sale under Rule 144 following an exercise of stock options and immediate cash payment. Key compliance elements are included: broker identification, number of shares, aggregate market value, approximate sale date, exchange, and confirmation of no sales in the prior three months. The mandatory representation regarding material nonpublic information is present, which aligns with Rule 144 procedural requirements. There are no disclosures of unusual restrictions, nonstandard payment arrangements, or prior recent dispositions that would complicate resale eligibility.

Securities Market Analyst

TL;DR: Commercially routine transaction; limited market impact information provided.

The notice shows a proposed sale of 4,896 common shares via a named broker with an aggregate market value of $355,694.40. The shares were acquired through option exercise the same day as the proposed sale, with cash payment recorded. The filing indicates nothing to report for sales in the past three months, suggesting this is not part of an ongoing disposition pattern disclosed here. From a market perspective, the filing provides transactional transparency but does not disclose any additional context that would suggest material impact on EXPO's capitalization or market dynamics.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4896	355694.40	50501135	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2025	Exercise of Stock Options	Issuer			4896	08/14/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of EXPO are being reported for sale in this Form 144?

The filer proposes to sell 4,896 shares of Exponent Inc common stock.

When is the approximate sale date for the EXPO securities?

The approximate date of sale is listed as 08/14/2025.

How were the EXPO shares acquired according to the filing?

The shares were acquired on 08/14/2025 by exercise of stock options from the issuer and paid for in cash.

Which broker is handling the proposed sale for EXPO shares?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services at the address provided.

What is the aggregate market value of the EXPO shares to be sold?

The aggregate market value is stated as $355,694.40.

Does the filing report any EXPO shares sold in the past three months?

No. The filing shows Nothing to Report for securities sold during the past three months by the reporting person.

On which exchange are the EXPO shares listed per this filing?

The securities are listed on NASDAQ as indicated in the filing.